
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12198575
[patent_doc_number] => 09901623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Rapid-acting insulin compositions'
[patent_app_type] => utility
[patent_app_number] => 15/241412
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17298
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241412 | Rapid-acting insulin compositions | Aug 18, 2016 | Issued |
Array
(
[id] => 11668476
[patent_doc_number] => 20170157196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/239708
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7585
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15239708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/239708 | Peptide fragments for inducing synthesis of extracellular matrix proteins | Aug 16, 2016 | Issued |
Array
(
[id] => 11289119
[patent_doc_number] => 20160339050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events'
[patent_app_type] => utility
[patent_app_number] => 15/225886
[patent_app_country] => US
[patent_app_date] => 2016-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22281
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15225886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/225886 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | Aug 1, 2016 | Issued |
Array
(
[id] => 13026449
[patent_doc_number] => 10035840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Targeted coagulation factors and method of using the same
[patent_app_type] => utility
[patent_app_number] => 15/222001
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7914
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/222001 | Targeted coagulation factors and method of using the same | Jul 27, 2016 | Issued |
Array
(
[id] => 13793325
[patent_doc_number] => 20190010201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => Polypeptide for Inhibition of Tumor
[patent_app_type] => utility
[patent_app_number] => 15/746978
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746978 | Polypeptide for inhibition of tumor | Jul 20, 2016 | Issued |
Array
(
[id] => 11362862
[patent_doc_number] => 20170000844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'Treatment of Ascites'
[patent_app_type] => utility
[patent_app_number] => 15/198050
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3118
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/198050 | Treatment of ascites | Jun 29, 2016 | Issued |
Array
(
[id] => 12904714
[patent_doc_number] => 20180193413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => MAMMALIAN GLUCOSIDASE INHIBITORS, METHODS FOR THEIR USE AND PHARMACEUTICAL COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/740494
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740494 | Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof | Jun 28, 2016 | Issued |
Array
(
[id] => 13675211
[patent_doc_number] => 20160376339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => DECOY PEPTIDES INHIBITING BINDING OF AMIGO2 AND 3-PHOSPHOINOSITIDE-DEPENDENT KINASE 1
[patent_app_type] => utility
[patent_app_number] => 15/195844
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15195844
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/195844 | Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 | Jun 27, 2016 | Issued |
Array
(
[id] => 12884986
[patent_doc_number] => 20180186837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/738730
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738730 | Broad-spectrum anti-infective peptides | Jun 23, 2016 | Issued |
Array
(
[id] => 11457167
[patent_doc_number] => 20170051072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'MODIFIED PSEUDOMONAS EXOTOXIN A'
[patent_app_type] => utility
[patent_app_number] => 15/191392
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 56953
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191392
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/191392 | MODIFIED PSEUDOMONAS EXOTOXIN A | Jun 22, 2016 | Abandoned |
Array
(
[id] => 13781019
[patent_doc_number] => 20190004048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/737850
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737850 | Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor | Jun 21, 2016 | Abandoned |
Array
(
[id] => 11541704
[patent_doc_number] => 20170095529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'ENDOMUCIN AS AN ANTI-INFLAMMATORY AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/178837
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 8580
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15178837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/178837 | ENDOMUCIN AS AN ANTI-INFLAMMATORY AGENT | Jun 9, 2016 | Abandoned |
Array
(
[id] => 13220633
[patent_doc_number] => 10124077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
[patent_app_type] => utility
[patent_app_number] => 15/176920
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 33
[patent_no_of_words] => 26601
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15176920
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/176920 | Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma | Jun 7, 2016 | Issued |
Array
(
[id] => 15355557
[patent_doc_number] => 10526379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Methods and products for fusion protein synthesis
[patent_app_type] => utility
[patent_app_number] => 15/578486
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 28445
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 467
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578486
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578486 | Methods and products for fusion protein synthesis | Jun 2, 2016 | Issued |
Array
(
[id] => 13182565
[patent_doc_number] => 10106786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Compositions and methods for modulating hemostasis
[patent_app_type] => utility
[patent_app_number] => 15/172904
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9251
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/172904 | Compositions and methods for modulating hemostasis | Jun 2, 2016 | Issued |
Array
(
[id] => 11114889
[patent_doc_number] => 20160311858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'PEPTIDE-COMPOUND CYCLIZATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/166550
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 222758
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/166550 | PEPTIDE-COMPOUND CYCLIZATION METHOD | May 26, 2016 | Abandoned |
Array
(
[id] => 11491483
[patent_doc_number] => 20170065668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'PAR-1 Activation by Metalloproteinase-1 (MMP-1)'
[patent_app_type] => utility
[patent_app_number] => 15/165988
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33669
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/165988 | PAR-1 Activation by Metalloproteinase-1 (MMP-1) | May 25, 2016 | Abandoned |
Array
(
[id] => 12791155
[patent_doc_number] => 20180155554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Conotoxin Peptides for Use in Biofouling Deterrence
[patent_app_type] => utility
[patent_app_number] => 15/576522
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576522 | Conotoxin peptides for use in biofouling deterrence | May 18, 2016 | Issued |
Array
(
[id] => 14665039
[patent_doc_number] => 10370410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Cancer cell-targeting peptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/575390
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8926
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575390
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575390 | Cancer cell-targeting peptide and use thereof | May 17, 2016 | Issued |
Array
(
[id] => 15068559
[patent_doc_number] => 10463745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Materials for tissue regeneration
[patent_app_type] => utility
[patent_app_number] => 15/573166
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 6
[patent_no_of_words] => 15139
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573166 | Materials for tissue regeneration | May 11, 2016 | Issued |